Literature DB >> 11501668

Role of Th2 cytokines, RANTES and eotaxin in AIDS-associated eosinophilic folliculitis.

P Amerio1, R Verdolini, G Proietto, C Feliciani, P Toto, G Shivji, F Loconsole, N Cassano, P Amerio1, G Vena, D N Sauder.   

Abstract

The pathogenesis of AIDS-associated eosinophilic folliculitis is still unknown. The expression of chemokines and Th2-type cytokines is increased in other conditions associated with tissue eosinophilia and in allergic reactions. We evaluated the mRNA expression by reverse transcriptase polymerase chain reaction of two Th2 cytokines (interleukin-4 and interleukin-5) and of two chemokines (RANTES and eotaxin) in the skin of 6 patients with AIDS-associated eosinophilic folliculitis; the tissue localization of eotaxin was shown by immunohistochemistry. We demonstrated the increased expression of interleukin-4, interleukin-5, RANTES and eotaxin in lesional skin of the patients compared to normal skin of HIV+ individuals. We concluded that a Th2 pattern is present in AIDS-associated eosinophilic folliculitis. The cytokine milieu in this disease may favour a Th2 immune response to an unknown antigen, whereby RANTES and eotaxin act in synergy with interleukin-4 and interleukin-5 to mediate tissue inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11501668     DOI: 10.1080/00015550152384191

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  10 in total

1.  Eosinophilic pustular folliculitis: association with long-term immunosuppressant use in a solid organ transplant recipient.

Authors:  Byung Wook Kim; Ji Hyun Lee; Chong Hyun Won; Sung Eun Chang; Mi Woo Lee; Jee Ho Choi; Kee Chan Moon
Journal:  Ann Dermatol       Date:  2014-07-31       Impact factor: 1.444

Review 2.  [Frequent and rare dermatological diseases in HIV patients].

Authors:  U R Hengge; R Mota; A Marini
Journal:  Hautarzt       Date:  2006-11       Impact factor: 0.751

Review 3.  Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract.

Authors:  Dagmar Simon; Andrew Wardlaw; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2010-04-14       Impact factor: 10.793

Review 4.  New insights into HIV-1-primary skin disorders.

Authors:  Filiberto Cedeno-Laurent; Minerva Gómez-Flores; Nora Mendez; Jesús Ancer-Rodríguez; Joseph L Bryant; Anthony A Gaspari; Jose R Trujillo
Journal:  J Int AIDS Soc       Date:  2011-01-24       Impact factor: 5.396

5.  Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis.

Authors:  Naoko Kataoka; Takahiro Satoh; Aiko Hirai; Kazumi Saeki; Hiroo Yokozeki
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

6.  Prevalence and risk factors for skin diseases among antiretroviral-naïve HIV-infected pregnant women in Dar es Salaam, Tanzania.

Authors:  Grace A Shayo; Candida Moshiro; Donna Spiegelman; Ferdinand M Mugusi; Guerino Chalamilla; Gernard Msamanga; Claudia Hawkins; Wafaie Fawzi
Journal:  Int J Dermatol       Date:  2014-07-29       Impact factor: 2.736

7.  Paradoxes in dermatology.

Authors:  Keshavmurthy A Adya; Arun C Inamadar; Aparna Palit
Journal:  Indian Dermatol Online J       Date:  2013-04

8.  Thalidomide in the Treatment of Sweet's Syndrome and Eosinophilic Folliculitis Associated With Immune Reconstitution Inflammatory Syndrome.

Authors:  Rong-Jing Dong; Shi-Zhen Huang; Pratishtha Upadhyay; Samip Shrestha; Ya-Jie Zhai; Yu-Ye Li
Journal:  Front Med (Lausanne)       Date:  2020-01-21

9.  Disseminated atypical molluscum contagiosum as a presenting symptom of HIV infection.

Authors:  Marta Filo-Rogulska; Malgorzata Pindycka-Piaszczyńska; Krzysztof Januszewski; Jerzy Jarząb
Journal:  Postepy Dermatol Alergol       Date:  2013-02-20       Impact factor: 1.837

Review 10.  Inflammatory dermatoses in human immunodeficiency virus.

Authors:  Taru Garg; Sarita Sanke
Journal:  Indian J Sex Transm Dis AIDS       Date:  2017 Jul-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.